Granules India’s two facilities located in Vizag in Andhra Pradesh and Jeedimetla in Telangana have completed U.S. Food and Drug Administration (US FDA) inspection. There are no observations for Vizag facility and 3 observations for Jeedimetla facility. The Company will respond to the observations in 15 business days.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
